A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy

por Kotsakis, A, Matikas, A, Koinis, F, Kentepozidis, N, Varthalitis, I I, Karavassilis, V, Samantas, Ep, Katsaounis, P, Dermitzaki, E K, Hatzidaki, D, Mavroudis, D, Georgoulias, V
Publicado 2016